Compare ADPT & WFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADPT | WFG |
|---|---|---|
| Founded | 2009 | 1955 |
| Country | United States | Canada |
| Employees | 624 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.0B |
| IPO Year | 2019 | 2007 |
| Metric | ADPT | WFG |
|---|---|---|
| Price | $28.51 | $71.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $17.78 | ★ $89.50 |
| AVG Volume (30 Days) | ★ 1.8M | 178.4K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.03% |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $276,976,000.00 | N/A |
| Revenue This Year | $3.98 | $5.05 |
| Revenue Next Year | $22.72 | $10.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 54.77 | N/A |
| 52 Week Low | $12.00 | $57.34 |
| 52 Week High | $28.72 | $76.99 |
| Indicator | ADPT | WFG |
|---|---|---|
| Relative Strength Index (RSI) | 73.65 | 58.48 |
| Support Level | $23.73 | $67.41 |
| Resistance Level | N/A | $72.66 |
| Average True Range (ATR) | 1.06 | 1.78 |
| MACD | 0.37 | 0.44 |
| Stochastic Oscillator | 97.40 | 78.19 |
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the Southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is one of the largest oriented strand board producers in the world.